737 related articles for article (PubMed ID: 8610364)
1. Mechanism by which additional monoclonal antibody (mAB) injections overcome the requirement for thymic irradiation to achieve mixed chimerism in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
Tomita Y; Khan A; Sykes M
Transplantation; 1996 Feb; 61(3):477-85. PubMed ID: 8610364
[TBL] [Abstract][Full Text] [Related]
2. Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
Tomita Y; Sachs DH; Khan A; Sykes M
Transplantation; 1996 Feb; 61(3):469-77. PubMed ID: 8610363
[TBL] [Abstract][Full Text] [Related]
3. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
[TBL] [Abstract][Full Text] [Related]
4. Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen. Peripheral mechanisms do not contribute to maintenance of tolerance.
Khan A; Tomita Y; Sykes M
Transplantation; 1996 Aug; 62(3):380-7. PubMed ID: 8779687
[TBL] [Abstract][Full Text] [Related]
5. Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance.
Wekerle T; Sayegh MH; Ito H; Hill J; Chandraker A; Pearson DA; Swenson KG; Zhao G; Sykes M
Transplantation; 1999 Nov; 68(9):1348-55. PubMed ID: 10573075
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic cell transplantation for the induction of allo- and xenotolerance.
Sykes M
Clin Transplant; 1996 Aug; 10(4):357-63. PubMed ID: 8884109
[TBL] [Abstract][Full Text] [Related]
7. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen.
Tomita Y; Khan A; Sykes M
J Immunol; 1994 Aug; 153(3):1087-98. PubMed ID: 8027542
[TBL] [Abstract][Full Text] [Related]
8. Intrathymic deletion of alloreactive T cells in mixed bone marrow chimeras prepared with a nonmyeloablative conditioning regimen.
Manilay JO; Pearson DA; Sergio JJ; Swenson KG; Sykes M
Transplantation; 1998 Jul; 66(1):96-102. PubMed ID: 9679828
[TBL] [Abstract][Full Text] [Related]
9. Induction of tolerance by mixed chimerism with nonmyeloblative host conditioning: the importance of overcoming intrathymic alloresistance.
Nikolic B; Khan A; Sykes M
Biol Blood Marrow Transplant; 2001; 7(3):144-53. PubMed ID: 11302548
[TBL] [Abstract][Full Text] [Related]
10. CD4 T cell-mediated alloresistance to fully MHC-mismatched allogeneic bone marrow engraftment is dependent on CD40-CD40 ligand interactions, and lasting T cell tolerance is induced by bone marrow transplantation with initial blockade of this pathway.
Ito H; Kurtz J; Shaffer J; Sykes M
J Immunol; 2001 Mar; 166(5):2970-81. PubMed ID: 11207246
[TBL] [Abstract][Full Text] [Related]
11. Minimal conditioning required in a murine model of T cell depletion, thymic irradiation and high-dose bone marrow transplantation for the induction of mixed chimerism and tolerance.
Wekerle T; Nikolic B; Pearson DA; Swenson KG; Sykes M
Transpl Int; 2002 May; 15(5):248-53. PubMed ID: 12012046
[TBL] [Abstract][Full Text] [Related]
12. Alloresistance to K locus class I-mismatched bone marrow engraftment is mediated entirely by CD4+ and CD8+ T cells.
Hayashi H; LeGuern C; Sachs DH; Sykes M
Bone Marrow Transplant; 1996 Aug; 18(2):285-92. PubMed ID: 8864436
[TBL] [Abstract][Full Text] [Related]
13. Anti-CD40L monoclonal antibodies can replace anti-CD4 monoclonal antibodies for the nonmyeloablative induction of mixed xenogeneic chimerism.
Ito H; Takeuchi Y; Shaffer J; Sykes M
Transplantation; 2006 Jul; 82(2):251-7. PubMed ID: 16858289
[TBL] [Abstract][Full Text] [Related]
14. Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning.
Sykes M; Szot GL; Swenson KA; Pearson DA
Nat Med; 1997 Jul; 3(7):783-7. PubMed ID: 9212108
[TBL] [Abstract][Full Text] [Related]
15. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach.
Colson YL; Li H; Boggs SS; Patrene KD; Johnson PC; Ildstad ST
J Immunol; 1996 Oct; 157(7):2820-9. PubMed ID: 8816385
[TBL] [Abstract][Full Text] [Related]
16. Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen.
Sharabi Y; Aksentijevich I; Sundt TM; Sachs DH; Sykes M
J Exp Med; 1990 Jul; 172(1):195-202. PubMed ID: 1972728
[TBL] [Abstract][Full Text] [Related]
17. Mixed allogeneic chimeras prepared by a non-myeloablative regimen: requirement for chimerism to maintain tolerance.
Sharabi Y; Abraham VS; Sykes M; Sachs DH
Bone Marrow Transplant; 1992 Mar; 9(3):191-7. PubMed ID: 1387333
[TBL] [Abstract][Full Text] [Related]
18. Both gamma delta T cells and NK cells inhibit the engraftment of xenogeneic rat bone marrow cells and the induction of xenograft tolerance in mice.
Nikolic B; Cooke DT; Zhao G; Sykes M
J Immunol; 2001 Jan; 166(2):1398-404. PubMed ID: 11145725
[TBL] [Abstract][Full Text] [Related]
19. Tolerization of Gal alpha 1,3Gal-reactive B cells in pre-sensitized alpha 1,3-galactosyltransferase-deficient mice by nonmyeloablative induction of mixed chimerism.
Ohdan H; Swenson KG; Kitamura H; Yang YG; Sykes M
Xenotransplantation; 2001 Nov; 8(4):227-38. PubMed ID: 11737848
[TBL] [Abstract][Full Text] [Related]
20. Production of donor T cells is critical for induction of donor-specific tolerance and maintenance of chimerism.
Xu H; Chilton PM; Huang Y; Schanie CL; Ildstad ST
J Immunol; 2004 Feb; 172(3):1463-71. PubMed ID: 14734723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
